A
ANEBULO PHARMACEUTICALS INC
NASDAQ: ANEB (Anebulo Pharmaceuticals Inc)
最近更新时间: 2小时之前0.003
0.00 (0.00%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Anebulo Pharmaceuticals Inc | 混合的 | 混合的 |
相关股票
| 股票 | 市值 | DY | P/E（TTM） | P/B |
|---|---|---|---|---|
| ANEB | - | - | - | 1.36 |
| IBRX | - | - | - | - |
| CNTN | - | - | - | 0.320 |
| TNGX | - | - | - | 4.19 |
| CORT | - | - | - | 9.62 |
| SLS | - | - | - | 12.28 |
AIStockmoo 评分
| 价值 35% | -1.7 |
| AI Insight 参考 | NA |
| 相对估值 参考 | NA |
| 财务健康 参考 | -1.7 |
| 时机 35% | -0.3 |
| AI Technical 参考 | NA |
| 技术振荡指标 参考 | -0.5 |
| 技术平均移动指标 参考 | 0.0 |
| 聪明钱 30% | 0.0 |
| 分析师共识 参考 | 0.0 |
| 内部交易活动 参考 | NA |
| 新闻情绪 参考 | NA |
| 市场环境 | ×1.21 |
| 宏观环境 参考 | -3.3 |
| 行业对比大市 (6个月) | -23.9% |
| 支柱一致性 | ×1.00 |
| 不计入评分 | |
| 价格波动 参考 | 0.8 |
| 最终评分 | -0.85 |
|
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 40.54% |
| 机构持股比例 | 55.05% |
投资组合